Purple Biotech Ltd
PPBT2.330USD
-0.290-11.07%
Close 07/25, 16:00（ET）Quotes delayed by 15 min
1.24BMarket Cap
LossP/E TTM
More Details of Purple Biotech Ltd Company
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
Company Info
Ticker SymbolPPBT
Company namePurple Biotech Ltd
IPO dateSep 03, 1978
Founded at1968
CEOMr. Gil Efron, CPA
Number of employees9
Security typeOrdinary Share
Fiscal year-endSep 03
Address4 Oppenheimer St.
CityREHOVOT
Stock exchangeTel Aviv Stock Exchange
CountryIsrael
Postal code7670104
Phone97239333121
Websitehttps://purple-biotech.com/
Ticker SymbolPPBT
IPO dateSep 03, 1978
Founded at1968
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Steven Steinberg
Mr. Steven Steinberg
Independent Director
Independent Director
--
--
Mr. Avraham Ben-Tzvi
Mr. Avraham Ben-Tzvi
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. Yisrael Gewirtz
Mr. Yisrael Gewirtz
Internal Auditor
Internal Auditor
--
--
Dr. Eric K. Rowinsky, M.D.
Dr. Eric K. Rowinsky, M.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. Gil Efron, CPA
Mr. Gil Efron, CPA
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Itzhak Israel
Mr. Itzhak Israel
Director
Director
--
--
Dr. Bertrand Liang
Dr. Bertrand Liang
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Arie Weber
Mr. Arie Weber
Independent Director
Independent Director
--
--
Ms. Revital Stern-Raff
Ms. Revital Stern-Raff
Independent Director
Independent Director
--
--
Dr. Hadas Reuveni
Dr. Hadas Reuveni
Founder and Chief Technology Officer of TyrNovo (a subsidiary)
Founder and Chief Technology Officer of TyrNovo (a subsidiary)
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Steven Steinberg
Mr. Steven Steinberg
Independent Director
Independent Director
--
--
Mr. Avraham Ben-Tzvi
Mr. Avraham Ben-Tzvi
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. Yisrael Gewirtz
Mr. Yisrael Gewirtz
Internal Auditor
Internal Auditor
--
--
Dr. Eric K. Rowinsky, M.D.
Dr. Eric K. Rowinsky, M.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. Gil Efron, CPA
Mr. Gil Efron, CPA
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Itzhak Israel
Mr. Itzhak Israel
Director
Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Tue, Jul 15
Updated: Tue, Jul 15
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
UBS Financial Services, Inc.
0.81%
Kingswood Wealth Advisors, LLC
0.59%
BNP Paribas Securities Corp. North America
0.19%
Morgan Stanley & Co. LLC
0.16%
GAMMA Investing LLC
0.16%
Other
98.10%
Shareholders
Shareholders
Proportion
UBS Financial Services, Inc.
0.81%
Kingswood Wealth Advisors, LLC
0.59%
BNP Paribas Securities Corp. North America
0.19%
Morgan Stanley & Co. LLC
0.16%
GAMMA Investing LLC
0.16%
Other
98.10%
Shareholder Types
Shareholders
Proportion
Investment Advisor
1.44%
Research Firm
0.35%
Investment Advisor/Hedge Fund
0.16%
Other
98.06%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
36
50.71K
1.79%
-206.29K
2025Q1
39
103.31K
6.70%
-153.87K
2024Q4
41
133.07K
5.02%
-58.34K
2024Q3
39
222.98K
11.78%
+111.64K
2024Q2
39
147.98K
8.71%
+1.90K
2024Q1
40
184.47K
11.90%
+40.99K
2023Q4
40
174.27K
11.63%
+106.33K
2023Q3
38
64.91K
3.14%
-5.47K
2023Q2
37
13.88K
1.30%
-49.49K
2023Q1
37
6.26K
0.60%
-57.26K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
UBS Financial Services, Inc.
23.02K
0.81%
+12.24K
+113.53%
Mar 31, 2025
Kingswood Wealth Advisors, LLC
16.80K
0.59%
-16.80K
-50.00%
Mar 31, 2025
BNP Paribas Securities Corp. North America
5.38K
0.19%
--
--
Mar 31, 2025
Morgan Stanley & Co. LLC
4.46K
0.16%
-600.00
-11.85%
Mar 31, 2025
Rhumbline Advisers Ltd. Partnership
805.00
0.03%
+200.00
+33.06%
Mar 31, 2025
RBC Dominion Securities, Inc.
107.00
0%
--
--
Mar 31, 2025
Northwestern Mutual Capital, LLC
85.00
0%
+85.00
--
Mar 31, 2025
SBI Securities Co., Ltd.
20.00
0%
-170.00
-89.47%
Mar 31, 2025
Global Retirement Partners, LLC
16.00
0%
--
--
Dec 31, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Sep 06, 2024
Merger
20<1
Sep 06, 2024
Merger
20<1
Sep 06, 2024
Merger
20<1
Sep 06, 2024
Merger
20<1
Aug 13, 2020
Merger
10<1
Aug 13, 2020
Merger
10<1
Date
Type
Ratio
Sep 06, 2024
Merger
20<1
Sep 06, 2024
Merger
20<1
Sep 06, 2024
Merger
20<1
Sep 06, 2024
Merger
20<1
Aug 13, 2020
Merger
10<1
Aug 13, 2020
Merger
10<1
Aug 13, 2020
Merger
10<1
Aug 13, 2020
Merger
10<1
